Vilje Bionics

Vilje Bionics is a verified Norwegian medical technology company developing the 'VilPower' (formerly ABELarm) full-arm exoskeleton for stroke rehabilitation. The project demonstrates high real-world utility and technical innovation, backed by significant milestones including ~$4M in funding, Forbes 30 Under 30 recognition, and clinical trials. However, the submission itself is of extremely low quality, containing false claims (e.g., 'most people have used my product', 'audience reach: everyone') and placeholder data. The score reflects the high potential of the actual technology, heavily penalized by the minimum Quality Factor (0.5) due to the lack of verifiable evidence provided in the submission text.